Insufficient Glycemic Control Increases Nuclear Factor-κB Binding Activity in Peripheral Blood Mononuclear Cells Isolated From Patients With Type 1 Diabetes

التفاصيل البيبلوغرافية
العنوان: Insufficient Glycemic Control Increases Nuclear Factor-κB Binding Activity in Peripheral Blood Mononuclear Cells Isolated From Patients With Type 1 Diabetes
المؤلفون: Hans J. Tritschler, Reinhard Ziegler, Peter Wahl, Marion A. Hofmann, Stephan Schiekofer, Angelika Bierhaus, Michael Kanitz, Michael Morcos, Martina Joswig, Peter P. Nawroth, Vong Lee, Martina S. Klevesath
المصدر: Diabetes Care. 21:1310-1316
بيانات النشر: American Diabetes Association, 1998.
سنة النشر: 1998
مصطلحات موضوعية: Adult, Blood Glucose, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, In Vitro Techniques, Peripheral blood mononuclear cell, Antioxidants, Lipid peroxidation, chemistry.chemical_compound, Diabetic Neuropathies, Internal medicine, Diabetes mellitus, Blood plasma, Internal Medicine, medicine, Humans, Glycemic, Glycated Hemoglobin, Advanced and Specialized Nursing, Type 1 diabetes, Thioctic Acid, business.industry, Monocyte, NF-kappa B, Nuclear Proteins, medicine.disease, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Endocrinology, medicine.anatomical_structure, chemistry, Leukocytes, Mononuclear, Regression Analysis, Lipid Peroxidation, business, Biomarkers
الوصف: OBJECTIVE The redox-sensitive transcription factor nuclear factor-kB (NF-kB) is believed to contribute to late diabetic complications. It is unknown whether NF-kB is influenced by glycemic control. RESEARCH DESIGN AND METHODS To determine whether NF-kB is activated in patients with insufficient glycemic control (HbA1c > 10%), we developed a tissue culture-independent electrophoretic mobility shift assay (EMSA)-based semiquantitative detection system that allowed us to determine NF-kB activation in ex vivo-isolated peripheral blood mononuclear cells (PBMCs). We included 43 patients with type 1 diabetes in this cross-sectional study. 10 of those received the antioxidant thioctic acid (600 mg/day p.o.) for 2 weeks. RESULTS Monocytes of patients with HbA1c levels > 10% demonstrated significantly higher NF-kB binding activity in an EMSA and a stronger NF-kB staining in immunohistochemistry than monocytes of patients with HbA1c levels of 6–8%. The increase in NF-kB activation correlated with an increase in plasmatic markers of lipid peroxidation. Treatment with the antioxidant thioctic acid decreased NF-kB binding activity. CONCLUSIONS Hyperglycemia induces activation of the transcription factor NF-kB in ex vivo-isolated PBMCs of patients with type 1 diabetes. NF-kB activation is at least partially dependent on oxidative stress, since the antioxidant thioctic acid significantly lowered the extent of NF-kB binding activity.
تدمد: 1935-5548
0149-5992
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e32f2b7080b2a193ae2a7a6dd21c6aeTest
https://doi.org/10.2337/diacare.21.8.1310Test
رقم الانضمام: edsair.doi.dedup.....2e32f2b7080b2a193ae2a7a6dd21c6ae
قاعدة البيانات: OpenAIRE